|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal Susitarimą)
| (51) | INT.CL. | C07K 16/18 | (2006.01) |
| C12N 15/13 | (2006.01) | ||
| C12N 5/10 | (2006.01) | ||
| A61K 39/00 | (2006.01) | ||
| A61P 25/28 | (2006.01) |
| (11) | Patento numeris | 3070100 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 16161726.1 |
| Europos patento paraiškos padavimo data | 2001-02-26 | |
| (97) | Europos patento paraiškos paskelbimo data | 2016-09-21 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2021-07-07 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (30) | Numeris | Data | Šalis |
| 184601 P | 2000-02-24 | US | |
| 254465 P | 2000-12-08 | US | |
| 254498 P | 2000-12-08 | US |
| (72) |
HOLTZMAN, David M. , US
DEMATTOS, Ronald , US
BALES, Kelly R , US
PAUL, Steven M. , US
TSURUSHITA, Naoya , US
VASQUEZ, Maximiliano , US
|
| (73) |
WASHINGTON UNIVERSITY ST. LOUIS ,
1 Brookings Drive,, St. Louis
Missouri 63110,
US
Eli Lilly & Company , Lilly Corporate Center, Indianapolis, IN 46285, US |
| (54) | HUMANIZED ANTIBODIES THAT SEQUESTER AMYLOID BETA PEPTIDE |
| HUMANIZED ANTIBODIES THAT SEQUESTER AMYLOID BETA PEPTIDE |